277 related articles for article (PubMed ID: 27125343)
21. Ethylene carbodiimide-fixed donor splenocytes combined with α-1 antitrypsin induce indefinite donor-specific protection to mice cardiac allografts.
Lai X; Qiu L; Zhao Y; Yu S; Wang C; Zhang J; Ning F; Chen L; Chen G
Transpl Int; 2017 Mar; 30(3):305-317. PubMed ID: 27957767
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of Inflammatory Cytokine Release from IL-1β and LPS-Stimulated PBMC Orchestrated by ST2825, a MyD88 Dimerisation Inhibitor.
Ramírez-Pérez S; Hernández-Palma LA; Oregon-Romero E; Anaya-Macías BU; García-Arellano S; González-Estevez G; Muñoz-Valle JF
Molecules; 2020 Sep; 25(18):. PubMed ID: 32967164
[TBL] [Abstract][Full Text] [Related]
23. Toll-Like Receptor 4 Deficiency Improves Short-term Renal Function but not Long-term Graft Survival in a Fully MHC-Mismatched Murine Model of Renal Allograft Transplantation.
Kwan TK; Chadban SJ; Wu H
Transplantation; 2016 Jun; 100(6):1219-27. PubMed ID: 27077596
[TBL] [Abstract][Full Text] [Related]
24. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
[TBL] [Abstract][Full Text] [Related]
25. TLR engagement prevents transplantation tolerance.
Chen L; Wang T; Zhou P; Ma L; Yin D; Shen J; Molinero L; Nozaki T; Phillips T; Uematsu S; Akira S; Wang CR; Fairchild RL; Alegre ML; Chong A
Am J Transplant; 2006 Oct; 6(10):2282-91. PubMed ID: 16970798
[TBL] [Abstract][Full Text] [Related]
26. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
[TBL] [Abstract][Full Text] [Related]
27. Divergent role of donor dendritic cells in rejection versus tolerance of allografts.
Ueno T; Tanaka K; Jurewicz M; Murayama T; Guleria I; Fiorina P; Paez JC; Augello A; Vergani A; Wong M; Smith RN; Abdi R
J Am Soc Nephrol; 2009 Mar; 20(3):535-44. PubMed ID: 19129312
[TBL] [Abstract][Full Text] [Related]
28. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
29. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
[TBL] [Abstract][Full Text] [Related]
30. A tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by activation of antigen-specific CD4+CD25+ T regulatory cells that promotes skin allograft survival in mice.
Fu BM; He XS; Yu S; Hu AB; Zhang J; Ma Y; Tam NL; Huang JF
Cell Immunol; 2010; 261(1):69-76. PubMed ID: 20038461
[TBL] [Abstract][Full Text] [Related]
31. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
Elster EA; Xu H; Tadaki DK; Montgomery S; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Marx R; Harlan DM; Kirk AD
Transplantation; 2001 Nov; 72(9):1473-8. PubMed ID: 11707732
[TBL] [Abstract][Full Text] [Related]
32. Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice.
Zhang Q; Nakaki T; Iwami D; Niimi M; Shirasugi N
Transplantation; 2009 Dec; 88(12):1360-70. PubMed ID: 20029332
[TBL] [Abstract][Full Text] [Related]
33. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells.
Nathan MJ; Yin D; Eichwald EJ; Bishop DK
Am J Transplant; 2002 Apr; 2(4):323-32. PubMed ID: 12118853
[TBL] [Abstract][Full Text] [Related]
34. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model.
Zhong T; Liu Y; Jiang J; Wang H; Temple CL; Sun H; Garcia B; Zhong R; Ross DC
Transplantation; 2007 Dec; 84(12):1636-43. PubMed ID: 18165776
[TBL] [Abstract][Full Text] [Related]
35. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
36. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
37. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
Markees TG; Phillips NE; Gordon EJ; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA
J Clin Invest; 1998 Jun; 101(11):2446-55. PubMed ID: 9616216
[TBL] [Abstract][Full Text] [Related]
38. Galectin-9 in combination with rapamycin induces cardiac allograft tolerance in mice.
Cai L; Zhou H; Fang Z; Yuan J; Niki T; Hirashima M; He W; Chen ZK
Transplantation; 2013 Aug; 96(4):379-86. PubMed ID: 23838998
[TBL] [Abstract][Full Text] [Related]
39. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
40. MYD88 Inhibitor ST2825 Suppresses the Growth of Lymphoma and Leukaemia Cells.
Shiratori E; Itoh M; Tohda S
Anticancer Res; 2017 Nov; 37(11):6203-6209. PubMed ID: 29061802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
